![]() |
Technical Data |
|
B0395-01H |
BCA-1, Recombinant, Human (B Cell Attracting Chemokine 1, BCA1, B Lymphocyte Chemoattractant, ANGIE, ANGIE2, BLC, BLR1 Ligand, BLR1L, Chemokine (C-X-C Motif) Ligand 13 (B-cell Chemoattractant), C-X-C Motif Chemokine 13, CXCL13, CXC Chemokine BLC, Small In |
20ug |
| Growth Factors, Cytokines | Storage: -20°CShipping: Blue Ice |
|
CXCL13 (B cell attracting chemokine I/BCA-1) is a newly discovered chemokine in the CXC family. CXCL13 is highly effective as an attractor of B lymphocytes that express BLR-1. Molecular Weight: ~10.1kD (85aa sequence) Source: Recombinant corresponding to human CXCL13 expressed in E.coli. Endotoxin: 0.1ng/mg Applications: Suitable for use in Functional Assays. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with 200ul sterile dH2O. Aliquot and store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
Source: Recombinant, expressed in E. coli Purity: Purified: ~98% (SDS PAGE, HPLC) Form: Supplied as a lyophilized powder in PBS, pH 7.2, 0.1% sodium azide. Preservative free. Reconstitute with 200ul sterile dH2O. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
|
||